Mimeault M - Search Results

1

Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.

Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Int J Cancer. 2006 Feb 15;118(4):1022-31. doi: 10.1002/ijc.21440. Int J Cancer. 2006. PMID: 16108016

2

New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.

Mimeault M, Bonenfant D, Batra SK. Mimeault M, et al. Skin Pharmacol Physiol. 2004 Jul-Aug;17(4):153-66. doi: 10.1159/000078818. Skin Pharmacol Physiol. 2004. PMID: 15258446 Review.

3

Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies.

Mimeault M, Batra SK. Mimeault M, et al. Ann Oncol. 2007 Oct;18(10):1605-19. doi: 10.1093/annonc/mdm070. Epub 2007 Mar 12. Ann Oncol. 2007. PMID: 17355951 Free article. Review.

4

Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1.

Mimeault M, Johansson SL, Batra SK. Mimeault M, et al. Br J Cancer. 2013 Mar 19;108(5):1079-91. doi: 10.1038/bjc.2012.484. Epub 2013 Feb 28. Br J Cancer. 2013. PMID: 23449353 Free PMC article.

5

Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines.

Mimeault M, Pommery N, Hénichart JP. Mimeault M, et al. Int J Cancer. 2003 Aug 10;106(1):116-24. doi: 10.1002/ijc.11171. Int J Cancer. 2003. PMID: 12794766

6

Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines.

Mimeault M, Jouy N, Depreux P, Hénichart JP. Mimeault M, et al. Prostate. 2005 Feb 1;62(2):187-99. doi: 10.1002/pros.20138. Prostate. 2005. PMID: 15389789

7

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

Mimeault M, Batra SK. Mimeault M, et al. Carcinogenesis. 2006 Jan;27(1):1-22. doi: 10.1093/carcin/bgi229. Epub 2005 Sep 29. Carcinogenesis. 2006. PMID: 16195239 Review.

8

Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Int J Cancer. 2007 Jan 1;120(1):160-9. doi: 10.1002/ijc.22268. Int J Cancer. 2007. PMID: 17013895

9

Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications.

Mimeault M, Batra SK. Mimeault M, et al. Cancer Metastasis Rev. 2007 Mar;26(1):203-14. doi: 10.1007/s10555-007-9052-4. Cancer Metastasis Rev. 2007. PMID: 17273942 Review.

10

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.

Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Mimeault M, et al. Mol Cancer Ther. 2007 Mar;6(3):967-78. doi: 10.1158/1535-7163.MCT-06-0648. Mol Cancer Ther. 2007. PMID: 17363490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters